Advertisement · 728 × 90

Posts by Zahra Kassamali Escobar

Post image Post image Post image Post image

@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025

fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA

1 year ago 75 33 2 2

Heterogeneity of treatment effect - making sure average effect doesn’t hide variability in response- The more you know 🌈

1 year ago 3 0 0 0
Post image

🚀 Learn from Drs. Erin McCreary and Zahra Kassamali Escobar at #MADID2025 about innovative treatment strategies for Gram-positive bloodstream infections! 💉✨

Register today! mad-idmembership.vfairs.com 🗓️

@erinmccreary.bsky.social
@zkepharmd.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social

1 year ago 5 2 0 0
Post image

🔍 Missed key updates in infectious diseases? Drs. Zahra Kassamali Escobar & Jamie L. Wagner have you covered at #MADID2025! 📢

Register now! 👉 mad-idmembership.vfairs.com 🗓️

@zkepharmd.bsky.social
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social

1 year ago 4 7 0 0
Post image

We’re not just treating asymptomatic bacteriuria—we’re also treating asymptomatic pyuria and nitrituria(ASPN). Madness!
🆕💫Study found ASPN led to 40% more unnecessary antibiotic use than ASB. Time to rethink our approach! #IDsky
cambridge.org/core/journals/…www.cambridge.org/core/journal...09

1 year ago 10 4 0 3